α-haloacetophenone derivatives as photoreversible covalent inhibitors of protein tyrosine phosphatases

Journal of the American Chemical Society

Volumn 121, Issue 21, 1999, Pages 5085-5086

  Arabaci, Gulnur ^a   Guo, Xiao Chuan ^a   Beebe, Kirk D ^a   Coggeshall, K Mark ^a   Pei, Dehua ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOPHENONE DERIVATIVE; PHOSPHOTYROSINE; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; B LYMPHOCYTE; CANCER; CATALYSIS; ENZYME ACTIVE SITE; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROLYSIS; HYDROPHOBICITY; IMMUNOPATHOLOGY; MASS SPECTROMETRY; PHOTOLYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0033516286     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja9906756     Document Type: Article

References (18)

1. Hunter, T. Cell 1995, 80, 225-236.
2. Neel, B. G.; Tonk, N. K. Curr. Opin. Cell Biol. 1997, 9, 193-204.
3. For a recent review, see: Burke, T. R.; Zhang, Z.-Y. Biopolymers 1998, 47, 225-241.
4. Dixon, J. E.; Zhang, Z.-Y. Adv. Enzymol. Relat. Areas Mol. Biol. 1994, 68, 1-36.
5. Compound 1a was synthesized as described: King, L. C.; Ostrum, G. K. J. Org. Chem. 1964, 29, 3459. Compound 1b is available from Fluka, whereas 1c and 1d were prepared as described under Supporting Information.
6. (a) Tonks, N. K.; Diltz, C. D.; Fischer, E. H. J. Biol. Chem. 1988, 263, 6722-6730.
7. (b) Tonks, N. K.; Diltz, C. D.; Fischer, E. H. J. Biol. Chem. 1988, 263, 6731-6737.
8. Feng, G.-S.; Pawson, T. Trends Genet. 1994, 10, 54-58.
9. Pei, D.; Neel, B. G.; Walsh, C. T. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1092-1096.
10. (a) Pei, D.; Lorenz, U.; Klingmuller, U.; Neel, B. G.; Walsh, C. T. Biochemistry 1994, 33, 15483-15493.
11. (b) Townley, R.; Shen, S.-H.; Banville, D.; Ramanchandran, C. Biochemistry 1993, 32, 13414-13418.
12. VHR hydrolyzes both pY and phosphoseryl/phosphothreonyl residues in proteins; it also uses a cysteine as the catalytic nucleophile but otherwise shares little sequence homology with PTPs (Zhou, G.; Denu, J. M.; Wu, L.; Dixon, J. E. J. Biol. Chem. 1994, 209, 28084-28090).
13. VHR has a shallower active site than a typical FTP and presumably has weaker interactions with the phenyl ring of a substrate or inhibitor (Yuvaniyama, J.; Denu, J. M.; Dixon, J. E.; Saper, M. A. Science 1996, 272, 1328-1331).
14. 1H NMR.
15. Givens, R. S.; Jung, A.; Park, C.-H.; Weber, J.; Bartlett, W. J. Am. Chem. Soc. 1997, 119, 8369-8370.
16. (a) Woodford-Thomas, T.; Thomas, M. L. Semin. Cell Biol. 1993, 4, 409-418.
17. (b) Gould, K. L.; Nurse, P. Nature 1989, 342, 39-45.
18. (c) Millar, J.; Russel, P. Cell 1992, 68, 407-410.